Dermatology

UCLA

Questions discussed in this category

In which clinical situations, if any, would you use imiquimod for treatment of breast cancer skin metastases?

1 Answer available

Papers discussed in this category

Clinical cancer research : an official journal of the American Association for Cancer Research, 2012-12-15

Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer.

JAMA oncology, 2017-07-01

Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases: A Phase 2 Clinical Trial.

Related Topics in Dermatology